Vifor Pharma - Company & Market Research Reports

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

From
From
From
From
Drug Overview: Feraheme - Product Thumbnail Image

Drug Overview: Feraheme

  • Drug Pipelines
  • 8 Pages
From
From
Hemochromatosis - Pipeline Review, H2 2018 - Product Thumbnail Image

Hemochromatosis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 38 Pages
From
Hemochromatosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Hemochromatosis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 41 Pages
From
Thalassemia - Pipeline Review, H2 2018 - Product Thumbnail Image

Thalassemia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 164 Pages
From
Thalassemia - Pipeline Review, H1 2018 - Product Thumbnail Image

Thalassemia - Pipeline Review, H1 2018

  • Drug Pipelines
  • 148 Pages
From
From
From
From
From
Loading Indicator
adroll